George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
" ...IQAI intends to take full advantage of the benefits orphan designation offers including assistance in the drug development process, tax credits, grant opportunities, and seven years of market exclusivity post-approval."
- particurlaly love this sentence!!
..... maybe IQAI will now do a proper interview and tell us how it sees the future of the company ....
--BB--
https://twitter.com/IQAI_IB/status/1630304392879407108
IB Neuro is the only DSC MRI perfusion package validated with the "low flip angle" approach which eliminates the need for the pre-load dose of Gadolinium - cutting Gad admin by 50% for perfusion exams without compromising image quality. @gbmfoundation @IQAI_IB @theABTA @TheASNR
-- BB --
https://twitter.com/IQAI_IB/status/1630278722736758786
"Coming soon! Updates to our website, a new service model, making IB clinically accessible to everyone!"
"IB Delta T1 - FDA cleared - Patent Pending"
-- BB --
If FDA says "yes" - then what happens?
If FDA says "no" - then what happens?
And I don't mean the SP ...
-- BB --
maybe TB should appoint this company - Alantra
https://www.alantra.com/ib-transaction/blackford-analysis-sell-side-advisory-bayer/
-- BB --
https://twitter.com/Blackford/status/1625050140867280904
from Blackford - We are delighted to officially become part of the #Bayer Radiology family. Bayer's well established arm's length model will empower us to continue our mission to improve the lives of patients by unlocking the adoption & benefits of medical imaging AI. #excitedforthefuture
-- BAYER acquired Blackford in January
-- Not sure why IQAI retweets this ... unless maybe (hopefully) ...
-- BB --
looks like it is US-centric by which companies/accounts it follows ... interesting to see who TB follows - mainly traders ... and Bayer!
-- BB --
56 billion Euros ... just saying!
-- BB --
I wonder how much was paid:
https://find-and-update.company-information.service.gov.uk/company/SC380297/filing-history
In 2021, sales at Bayer's radiology business with its contrast agents, injection systems and software accounted for 1.8 billion euros ($1.95 billion) of 44 billion euros in group sales.
During the third quarter of last year the radiology business saw sales increase 7% on growing demand for scans of cardiovascular disease and tumours.
IB Delta T1 maps (patent-pending & FDA cleared) are perfect for this! Supermaximal resection assessment. Highly prognostic and automated! Prognostic validation of a new classification system for extent of resection in glioblastoma: a report of the RANO …
https://pubmed.ncbi.nlm.nih.gov/35961053/
-- BB --
One would think ... if only to give shareholders a smidgen of warmth ...
-- BB --
IB Diffusion, a whole-body application, has been acquired for a multi-site breast cancer study. The study investigators were made aware of IB Diffusion via IB's long-standing involvement with the NCI's Quantitative Imaging Network (QIN). Great to see expanded use of IB's tools!
-- RNS to follow?? --
-- BB --
http://files.imagingbiometrics.com/v/ncRczEChiDbV3VxXGzqfm9nsw
Quite powerful stuff from Imaging Biometrics
-- BB --
very interesting - especially the companies that hold the most FDA authorisations - GE, Siemens, Canon, Aidoc and Philips. All multi-billion dollar companies in the medical AI space ...
-- BB --
I am with you ... am on the same journey!
hope to despair, hope to despair ...
I do believe in the tech ... and the applications will be groundbreaking ... if they ever get more widely used.
Need some news from the FDA - as a start ... well, actually just some news would be good.
I am heartened by the Tweets - in that IQAI is still being talked about.
Hopefully there is much going on behind closed doors ... but will an sp like we have now, I am not holding my breath ... huff ...
-- BB --
eek!
-- BB --
there already is a US listing!
OTCQB:IQAIF
-- BB --
https://www.lse.co.uk/rns/IQAI/directors-interest-99rxup1l39r4a15.html - from December 2021. He relinquished his place at the company ... AND a quick check on companies house and Trevor is not there anymore ... but his son his-... ! Just joining dots ... !
-- BB --
Um - I think he passed those shares to his son?
-- BB --